• Ionis Licenses Investigational Alzheimer's Therapy americanpharmaceuticalreview
    December 23, 2019
    Ionis Pharmaceuticals announced Biogen, a collaboration partner for neurological diseases, has licensed IONIS-MAPTRx, an antisense therapy designed to selectively reduce production ...
PharmaSources Customer Service